{"id":"cannabidiol-cbd-extract","safety":{"commonSideEffects":[{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Changes in appetite"},{"rate":null,"effect":"Hepatotoxicity"},{"rate":null,"effect":"Drug-drug interactions via CYP3A4/CYP2C19 inhibition"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CBD acts as a negative allosteric modulator of CB1 and CB2 cannabinoid receptors and interacts with serotonin (5-HT1A), vanilloid (TRPV1), and glycine receptors. These interactions produce anti-inflammatory, anxiolytic, and anticonvulsant effects without the psychoactive properties of THC. The exact therapeutic mechanism varies by indication but generally involves modulation of neuroinflammation and excitatory neurotransmission.","oneSentence":"Cannabidiol modulates endocannabinoid signaling and multiple receptor pathways to reduce inflammation, anxiety, and seizure activity.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:04:52.085Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seizure disorders (epilepsy)"},{"name":"Anxiety disorders"},{"name":"Chronic pain and inflammation"}]},"trialDetails":[{"nctId":"NCT07498023","phase":"PHASE1, PHASE2","title":"EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2025-09-15","conditions":"Fibromyalgia","enrollment":36},{"nctId":"NCT07016971","phase":"PHASE1","title":"CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-04-01","conditions":"Chemotherapy-Induced Peripheral Neuropathy","enrollment":12},{"nctId":"NCT07459920","phase":"PHASE2","title":"Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2026-04-01","conditions":"Advanced Malignant Solid Tumor","enrollment":156},{"nctId":"NCT07279558","phase":"PHASE2","title":"Cannabidiol and Alcohol Use Disorder Phenotypes","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02-01","conditions":"Alcohol Use Disorder","enrollment":180},{"nctId":"NCT07359976","phase":"NA","title":"Pharmacokinetic Evaluation of a Natural CBD Extract","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-01-04","conditions":"Pharmacokinetics of CBD Extract, Oral and Topical Administrations","enrollment":20},{"nctId":"NCT07298408","phase":"PHASE1, PHASE2","title":"Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Florida A&M University","startDate":"2026-01-02","conditions":"Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies","enrollment":20},{"nctId":"NCT07301658","phase":"NA","title":"Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis.","status":"COMPLETED","sponsor":"i+Med S.Coop.","startDate":"2023-02-27","conditions":"Atopic Dermatitis (AD)","enrollment":42},{"nctId":"NCT07224932","phase":"PHASE2","title":"Tolerability and Efficacy of CBD Extract for RLS Treatment","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2025-12-19","conditions":"Restless Leg Syndrome","enrollment":60},{"nctId":"NCT04816994","phase":"PHASE3","title":"Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2018-01-07","conditions":"Acute Radicular Back Pain, Cannabis","enrollment":200},{"nctId":"NCT06414473","phase":"PHASE1, PHASE2","title":"CBD for Knee Osteoarthritis","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-06-14","conditions":"Osteoarthritis, Knee","enrollment":30},{"nctId":"NCT06538389","phase":"PHASE2","title":"High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-08-26","conditions":"Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8","enrollment":36},{"nctId":"NCT07091747","phase":"PHASE1, PHASE2","title":"Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase","status":"ACTIVE_NOT_RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2025-04-07","conditions":"Alzheimer Disease (AD)","enrollment":61},{"nctId":"NCT04586712","phase":"PHASE2","title":"Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-03-01","conditions":"Muscle Injury, Recovery, Pain Relief","enrollment":34},{"nctId":"NCT06588972","phase":"PHASE2","title":"Analgesic Effects of a Treatment With Cannabis Sativa Extract in Patients With Knee Osteoarthritis - CANOA (Cannabis for Osteoarthritis)","status":"COMPLETED","sponsor":"Federal University of Latin American Integration","startDate":"2024-01-01","conditions":"OSTEOARTHRITIS OF THE KNEE","enrollment":45},{"nctId":"NCT07023744","phase":"PHASE2","title":"CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children","status":"NOT_YET_RECRUITING","sponsor":"University of Manitoba","startDate":"2025-10-01","conditions":"Drug Resistant Epilepsy","enrollment":90},{"nctId":"NCT05630235","phase":"PHASE1, PHASE2","title":"Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-06-16","conditions":"SCI - Spinal Cord Injury, Neuropathic Pain","enrollment":20},{"nctId":"NCT05337033","phase":"PHASE2","title":"Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2024-10-11","conditions":"Chronic Migraine","enrollment":20},{"nctId":"NCT05754840","phase":"PHASE1, PHASE2","title":"CANnabinoids in Pediatric ONCology","status":"NOT_YET_RECRUITING","sponsor":"University of Manitoba","startDate":"2025-06","conditions":"Childhood Cancer, Cancer","enrollment":60},{"nctId":"NCT06523725","phase":"PHASE2","title":"Trial Investigating the Safety and Efficacy of BRC-003 in Refractory Post-Traumatic Epilepsy","status":"WITHDRAWN","sponsor":"Dr. Paul Lyons","startDate":"2024-11-01","conditions":"Post-traumatic Epilepsy","enrollment":""},{"nctId":"NCT04527003","phase":"PHASE3","title":"Cannabidiol and Management of Endometriosis Pain","status":"TERMINATED","sponsor":"Milton S. Hershey Medical Center","startDate":"2020-12-04","conditions":"Endometriosis, CBD, Pelvic Pain","enrollment":12},{"nctId":"NCT06574100","phase":"PHASE1","title":"Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults","status":"RECRUITING","sponsor":"University of Saskatchewan","startDate":"2024-10-26","conditions":"Pharmacokinetics","enrollment":20},{"nctId":"NCT05985850","phase":"PHASE2","title":"Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy","status":"RECRUITING","sponsor":"BC Centre on Substance Use","startDate":"2024-05-23","conditions":"Opioid Use Disorder, Methadone, Cannabis","enrollment":24},{"nctId":"NCT06672666","phase":"PHASE2","title":"Use of CBD in the Treatment of Anxiety","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-01-06","conditions":"Anxiety, Generalized Anxiety Disorder, Sleep Problems","enrollment":30},{"nctId":"NCT04280289","phase":"EARLY_PHASE1","title":"CBD Cannabis Extract: Pharmacokinetic Studies","status":"COMPLETED","sponsor":"University of Mississippi, Oxford","startDate":"2021-02-01","conditions":"Epilepsy","enrollment":10},{"nctId":"NCT03582137","phase":"PHASE2","title":"A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-09-05","conditions":"Parkinson Disease","enrollment":74},{"nctId":"NCT06393101","phase":"PHASE1","title":"The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-06-01","conditions":"Complex Regional Pain Syndrome","enrollment":52},{"nctId":"NCT04634136","phase":"NA","title":"Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-10-15","conditions":"Children, Adult, Spastic Cerebral Palsy, Quality of Life","enrollment":55},{"nctId":"NCT03676049","phase":"","title":"Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)","status":"AVAILABLE","sponsor":"John","startDate":"","conditions":"Drug Resistant Epilepsy","enrollment":""},{"nctId":"NCT02283281","phase":"PHASE2, PHASE3","title":"Anesthetic Premedication With a Cannabis Extract (Cannapremed)","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2015-05","conditions":"Pain, Postoperative, Postoperative Nausea and Vomiting, Anxiety","enrollment":200},{"nctId":"NCT06137027","phase":"EARLY_PHASE1","title":"Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting","status":"UNKNOWN","sponsor":"The University of The West Indies","startDate":"2023-09-21","conditions":"Postoperative Nausea and Vomiting","enrollment":120},{"nctId":"NCT01606137","phase":"PHASE3","title":"A Study of the Long-term Safety of Sativex Use","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2002-02","conditions":"Multiple Sclerosis, Spasticity, Pain","enrollment":507},{"nctId":"NCT00678795","phase":"PHASE3","title":"A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2002-08","conditions":"Detrusor Overactivity, Multiple Sclerosis","enrollment":135},{"nctId":"NCT00674609","phase":"PHASE3","title":"A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2002-02","conditions":"Palliative Care, Pain, Cancer","enrollment":177},{"nctId":"NCT00675948","phase":"PHASE3","title":"Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2002-04","conditions":"Pain, Cancer","enrollment":43},{"nctId":"NCT04997954","phase":"PHASE4","title":"EMERALD TRIAL Open Label Extension Study","status":"UNKNOWN","sponsor":"Gold Coast Hospital and Health Service","startDate":"2021-05-17","conditions":"Amyotrophic Lateral Sclerosis, Cannabis, CBD","enrollment":7},{"nctId":"NCT01606189","phase":"PHASE3","title":"A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2001-12","conditions":"Pain","enrollment":48},{"nctId":"NCT01606202","phase":"PHASE3","title":"A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2002-07","conditions":"Pain","enrollment":116},{"nctId":"NCT01610687","phase":"PHASE3","title":"A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2001-07","conditions":"Multiple Sclerosis, Spasticity","enrollment":137},{"nctId":"NCT01604265","phase":"PHASE3","title":"A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2002-03","conditions":"Multiple Sclerosis, Neuropathic Pain","enrollment":66},{"nctId":"NCT04997616","phase":"EARLY_PHASE1","title":"Determination of Cannabinoid and Cannabinoid Metabolite Levels in Healthy Volunteers","status":"WITHDRAWN","sponsor":"University of Arkansas","startDate":"2023-01-03","conditions":"Healthy","enrollment":""},{"nctId":"NCT05503147","phase":"PHASE1","title":"Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)","status":"UNKNOWN","sponsor":"Ove Andersen","startDate":"2022-03-24","conditions":"Malnutrition, Anorexia, Cannabis","enrollment":17},{"nctId":"NCT05003882","phase":"","title":"Radicle ACES: A Study of Commercially Available CBD Used in the Real-world Setting","status":"COMPLETED","sponsor":"Radicle Science","startDate":"2021-08-02","conditions":"Pain, Sleep Disturbance, Anxiety","enrollment":3000},{"nctId":"NCT03328676","phase":"PHASE2","title":"The Effect of Cannabis on Dementia Related Agitation and Aggression","status":"COMPLETED","sponsor":"TO Pharmaceuticals","startDate":"2017-12-07","conditions":"Agitation Related to Dementia","enrollment":64},{"nctId":"NCT04726475","phase":"PHASE1, PHASE2","title":"Impact of CBD-Rich Oil on Aversive Memory Reconsolidation","status":"UNKNOWN","sponsor":"University of Texas at Austin","startDate":"2022-01","conditions":"Anxiety and Fear","enrollment":96},{"nctId":"NCT02983695","phase":"PHASE1","title":"Cannabinoid Therapy for Pediatric Epilepsy","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2017-02-02","conditions":"Epilepsy","enrollment":20},{"nctId":"NCT05115318","phase":"","title":"The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2020-07-01","conditions":"Tourette Syndrome, Cannabis","enrollment":18},{"nctId":"NCT05106504","phase":"","title":"Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2021-09-02","conditions":"Bladder, Overactive, Parkinson Disease","enrollment":100},{"nctId":"NCT03929835","phase":"PHASE2","title":"Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa","status":"WITHDRAWN","sponsor":"TO Pharmaceuticals","startDate":"2020-09-01","conditions":"Hidradenitis Suppurativa","enrollment":""},{"nctId":"NCT04842383","phase":"EARLY_PHASE1","title":"Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series","status":"UNKNOWN","sponsor":"Gregory L Smith, MD, MPH","startDate":"2021-04-05","conditions":"Androgenetic Alopecia","enrollment":40},{"nctId":"NCT03808935","phase":"PHASE3","title":"Cannabis Extract in Refractory Epilepsy Study","status":"TERMINATED","sponsor":"The Epilepsy Research Program of the Ontario Brain Institute","startDate":"2019-01-10","conditions":"Drug Resistant Epilepsy","enrollment":17},{"nctId":"NCT04086342","phase":"PHASE2","title":"CHI-902 for Treatment of Social Anxiety Disorder","status":"WITHDRAWN","sponsor":"Canopy Growth Corporation","startDate":"2020-01-24","conditions":"Social Anxiety Disorder","enrollment":""},{"nctId":"NCT02956226","phase":"PHASE2","title":"Cannabinoids for Behavioral Problems in Children With ASD","status":"COMPLETED","sponsor":"Shaare Zedek Medical Center","startDate":"2017-01","conditions":"Autistic Disorder","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":29,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Hemp Supplement"],"phase":"phase_3","status":"active","brandName":"Cannabidiol (CBD) Extract","genericName":"Cannabidiol (CBD) Extract","companyName":"Milton S. Hershey Medical Center","companyId":"milton-s-hershey-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cannabidiol modulates endocannabinoid signaling and multiple receptor pathways to reduce inflammation, anxiety, and seizure activity. Used for Seizure disorders (epilepsy), Anxiety disorders, Chronic pain and inflammation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}